Or it could be the start of one last shakedown to make investors doubt, or lead them to believe results will be bad. Sharks will bid the the opposite of which way they believe it will go to create greater volatility. If it drops, I load up...
Save the victory lap until you win mensa, INO is sitting pretty much where it was pre split. The shorts did jump on It today and it fell from its 25% gain back to the jump point , but you can't call it a win until it's a win. Maybe tomorrow though.
Yo Alice, you done fell down the wrong rabbit hole, it wasn't a rabbit and a hare it was Mitch McConnell and the hare, I mean , a tortoise. Now I'm messed up, give me some of those mushrooms!
Sacks, Fidelity et al close the door AFTER the horse has left the barn. These are bargain prices just like we had 12 months ago before the big run. Added another 13 k today, to the bunch I got yesterday.
Do you see how many shorts and negative poster have shown up? Did you like the stock at $3 ? If yes, you should love it at $2. The science has not changed. I continue to re-load at levels I never thought we would see again. I picked 1.92, as my bottom when we were at 2.83. We got there and momentarily below and my buy got filled. Happy days!
Mensa_I963 is not mensa_1963. Ignore the fraud .ID created May 9, 2014, yesterday. While the original is pompous, he has made very good points and is obviously knowledgeable.
Another way the market is stacked against the small investor, along with 3 day free ride BS. In the meantime Wall Street gets to see everything that is out there on bids and asks, no worries about cash positions. And when you trade your bids are trumped by the computer models. Cattle in the stockyard have a better chance.
MNKD got approval and sprinted up to --- where it was in January and below where it was last year. Some stock.
Fact Harry 261 was invented in February 2014. Opinion, after you place him on ignore, Harry 262 will be invented on April1, 2014. How appropriate.
1) RS is institutionally driven, they want in ASAP. 2) Don't be surprised if this shoots up above $5 near term as they drive it to a level where they can add shares in their flagship accounts 3) R/S will be there to protect the PPS in event of Phase II hiccup. (don't expect a rejection, but FDA could want to tweak the study that would delay approval process-not saying it will happen but biotech investors know how this works).
Rec: buy em if you can, all of the RS discussion is just static and is intended only to scare the uninitiated. Tuck this away and check back in 3 years, sooner only if you need the cash . You will be pleased.
Somebody had to say it, even though there is nothing to support this. So tomorrow, if a panic takes this down even more, I plan to load up as much as I can buy. Nothing has changed, simple as that.
Far fetched to say the least. Merck was retasking its R&D, Pierce got a golden handshake, nice severance, and now gets to works in a far less constrained and energized environment, make a name for himself with some breakthrough microcap biotech. Smooth move.